Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc. - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) # Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc. ##### Up next ###### [FancyTech Closes Series B+ to Power AI Personalized Content Solutions in Thailand and Southeast Asia](https://thailandbusinessnews.net/press-release/fancytech-closes-series-b-to-power-ai-personalized-content-solutions-in-thailand-and-southeast-asia/) Published on 07 May 2025 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) ![](https://mma.prnasia.com/media2/751177/Aji_BioPharma_Logo.jpg?p=medium600 "logo") AJICAP® Antibody-Drug Conjugate Manufacturing Technology Contributes to Enhanced Efficacy of Antibody Drugs TOKYO, May 7, 2025 /PRNewswire/ — Ajinomoto Co., Inc. (President: Shigeo Nakamura, Headquarters: Chuo-ku, Tokyo, hereinafter referred to as "Ajinomoto") has been conducting joint research\* with RIBOMIC Inc. (President: Yoshikazu Nakamura, Headquarters: Minato-ku, Tokyo, hereinafter referred to as "RIBOMIC"), a drug discovery startup focused on the development and production of aptamer pharmaceuticals, on the development of technology for controlling the pharmacokinetics of nucleic acid aptamers using the antibody-drug conjugate (ADC) manufacturing technology "AJICAP®" (hereinafter referred to as "AJICAP®"). As a result of this research, RIBOMIC has successfully extended the half-life of a conjugate of nucleic acid aptamers and the Fc region of immunoglobulins in the bloodstream. As part of our efforts to demonstrate the applicability of AJICAP®, we have been advancing joint research with RIBOMIC (disclosed on December 27, 2023) aimed at realizing next-generation aptamer pharmaceuticals. In this research, RIBOMIC has focused on the retention of immunoglobulins in the bloodstream and aims to develop technology to extend the half-life in the bloodstream by fusing nucleic acid aptamers with immunoglobulins. By combining RIBOMIC’s compound creation and measurement technology for nucleic acid aptamers with our AJICAP®, we have worked on creating a conjugate in which nucleic acid aptamers are covalently bonded to the Fc region, a partial protein of immunoglobulins. Through this effort, we have examined the binding ratio and linker structure of the Fc region and nucleic acid aptamers, and the results suggest that adjusting the binding ratio to 1:1 can significantly extend the half-life of nucleic acid aptamers in the bloodstream (see inserted figure). [![](https://mma.prnasia.com/media2/2679897/Ajinomoto_research.jpg?p=medium600)](https://mma.prnasia.com/media2/2679897/Ajinomoto_research.jpg?p=medium600) As demonstrated in this joint research, AJICAP® can be applied to the creation of conjugates of various bioactive molecules and antibodies. The resulting antibody-bioactive substance conjugates are expected to contribute to overcoming challenges such as improving the efficacy, stability, and safety of antibody drugs that have been apparent until now. Furthermore, the results of this joint research demonstrate the potential for AJICAP® to be applied not only to ADCs but also to various modalities. We will continue to provide unique value through antibody modification using AJICAP®. \*This does not grant RIBOMIC exclusive rights to the AJICAP® technology. About Ajinomoto Co., Inc. The Ajinomoto Group will contribute to the well-being of all human beings, our society and our planet with "AminoScience" based on the corporate slogan "Eat Well, Live Well". The Ajinomoto Group has offices in 34 countries and regions, and sells products in more than 130 countries and regions. In fiscal 2023, sales were 1.4392 trillion yen (9.9 billion U.S. dollars). To learn more, visit [www.ajinomoto.com](https://c212.net/c/link/?t=0&l=en&o=4420319-1&h=1403829448&u=https%3A%2F%2Fwww.ajinomoto.com%2F&a=www.ajinomoto.com). About RIBOMIC, Inc. As a drug discovery biotech venture, RIBOMIC, Inc. focuses on the development of aptamer pharmaceuticals, which are expected to be next-generation drugs, targeting a wide range of unmet medical needs such as pain, eye disorders, and bone diseases. They are also applying their RiboART System® to fields other than drug discovery, working on the development of new applications for aptamers outside of pharmaceuticals. For more information, please visit [https://www.ribomic.com](https://c212.net/c/link/?t=0&l=en&o=4420319-1&h=1758471801&u=https%3A%2F%2Fwww.ribomic.com%2F&a=https%3A%2F%2Fwww.ribomic.com). For further information, please contact: [HERE](https://c212.net/c/link/?t=0&l=en&o=4420319-1&h=782908866&u=https%3A%2F%2Fuser.pr-automation.jp%2Fpr-automation%2Fcoverage_request.php%3Fkey%3D6nqh4A9ZjhgUto3QypZK_w%253D%253D%26lang%3Den&a=HERE) Visit our [LinkedIn profile](https://c212.net/c/link/?t=0&l=en&o=4420319-1&h=2976034602&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fajibio-pharma-services%2F&a=LinkedIn+profile). Photo – [https://mma.prnasia.com/media2/2679897/Ajinomoto\_research.jpg?p=medium600](https://c212.net/c/link/?t=0&l=en&o=4420319-1&h=3367031908&u=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2679897%2FAjinomoto_research.jpg&a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2679897%2FAjinomoto_research.jpg)Logo – [https://mma.prnasia.com/media2/751177/Aji\_BioPharma\_Logo.jpg?p=medium600](https://c212.net/c/link/?t=0&l=en&o=4420319-1&h=182627308&u=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F751177%2FAji_BioPharma_Logo.jpg&a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F751177%2FAji_BioPharma_Logo.jpg) [Source link ](https://www.prnasia.com/story/archive/4680207_AE80207_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/from-affordable-premiums-to-holistic-care-policybazaar-unveils-comprehensive-solutions-for-nris-and-their-families-in-india/) ## From Affordable Premiums to Holistic Care, Policybazaar Unveils Comprehensive Solutions for NRIs and Their Families in India GURUGRAM, India, May 16, 2025 /PRNewswire/ — Policybazaar, one of India’s largest… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - May 16, 2025 [](https://thailandbusinessnews.net/press-release/sohu-com-limited-announces-its-2025-annual-report-on-form-20-f-is-available-on-the-companys-website/) ## Sohu.com Limited Announces its 2025 Annual Report on Form 20-F is Available on the Company's Website BEIJING, March 12, 2026 /PRNewswire/ — Sohu.com Limited (NASDAQ: SOHU) ("Sohu" or… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - March 12, 2026 [](https://thailandbusinessnews.net/press-release/telix-completes-acquisition-of-next-generation-therapeutic-assets-and-innovative-biologics-technology-platform/) ## Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform MELBOURNE, Australia and INDIANAPOLIS, Jan. 31, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX:… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - January 31, 2025 ##### Most Read - [![Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/priority-pass-to-accelerate-travel-innovation-backed-by-the-collinson-groups-500-million-growth-programme-2/ "Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme") [Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme](https://thailandbusinessnews.net/press-release/priority-pass-to-accelerate-travel-innovation-backed-by-the-collinson-groups-500-million-growth-programme-2/ "Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme") - [![DORCO Tinkle Is Awarded with 2026 IDEA Finalist for Brand Renewal](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/dorco-tinkle-is-awarded-with-2026-idea-finalist-for-brand-renewal/ "DORCO Tinkle Is Awarded with 2026 IDEA Finalist for Brand Renewal") [DORCO Tinkle Is Awarded with 2026 IDEA Finalist for Brand Renewal](https://thailandbusinessnews.net/press-release/dorco-tinkle-is-awarded-with-2026-idea-finalist-for-brand-renewal/ "DORCO Tinkle Is Awarded with 2026 IDEA Finalist for Brand Renewal") - [![DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/dorco-wins-2026-red-dot-award-for-renewed-corporate-identity/ "DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity") [DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity](https://thailandbusinessnews.net/press-release/dorco-wins-2026-red-dot-award-for-renewed-corporate-identity/ "DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity") - [![Dragonpass: AI Is Shifting the Membership Economy from Perks Redemption to Personalized Experiences](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/dragonpass-ai-is-shifting-the-membership-economy-from-perks-redemption-to-personalized-experiences/ "Dragonpass: AI Is Shifting the Membership Economy from Perks Redemption to Personalized Experiences") [Dragonpass: AI Is Shifting the Membership Economy from Perks Redemption to Personalized Experiences](https://thailandbusinessnews.net/press-release/dragonpass-ai-is-shifting-the-membership-economy-from-perks-redemption-to-personalized-experiences/ "Dragonpass: AI Is Shifting the Membership Economy from Perks Redemption to Personalized Experiences") - [![Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material](https://i0.wp.com/r2.thailandbusinessnews.net/2025/04/MODERN_MEADOW_LOGO_BLACK_PNG_Logo.jpg?fit=597%2C138&ssl=1&resize=40%2C40)](https://thailandbusinessnews.net/press-release/modern-meadow-and-bellroy-partner-on-carry-products-made-of-next-generation-material/ "Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material") [Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material](https://thailandbusinessnews.net/press-release/modern-meadow-and-bellroy-partner-on-carry-products-made-of-next-generation-material/ "Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material") - [![Oracle Unveils Fusion Claw + Expands Agentic Applications: NYSE Content Update](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/oracle-unveils-fusion-claw-expands-agentic-applications-nyse-content-update/ "Oracle Unveils Fusion Claw + Expands Agentic Applications: NYSE Content Update") [Oracle Unveils Fusion Claw + Expands Agentic Applications: NYSE Content Update](https://thailandbusinessnews.net/press-release/oracle-unveils-fusion-claw-expands-agentic-applications-nyse-content-update/ "Oracle Unveils Fusion Claw + Expands Agentic Applications: NYSE Content Update") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/frost-sullivan-launches-top-performers-program-to-spotlight-overlooked-high-performing-college-programs/) ## Frost & Sullivan Launches Top Performers Program to Spotlight Overlooked, High-Performing College Programs New program combines independent market analysis, program-level insights, and ongoing… [](https://thailandbusinessnews.net/press-release/health-in-tech-launches-hitrix-to-modernize-the-nearly-1-trillion-u-s-self-funded-health-insurance-market-and-announces-updated-2026-full-year-revenue-guidance/) ## Health In Tech Launches HitRix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance AI-powered HitRix platform streamlines large-group submissions, multi-market quoting,… [](https://thailandbusinessnews.net/press-release/arbitral-tribunal-reaffirms-koreas-liability-to-elliott-for-corrupt-intervention-in-2015-samsung-merger/) ## Arbitral Tribunal Reaffirms Korea's Liability to Elliott for Corrupt Intervention in 2015 Samsung Merger Elliott awarded approximately US $113 million Elliott hopes the ROK will finally… [](https://thailandbusinessnews.net/press-release/advantech-launches-asr-d501-ai-companion-computer-for-autonomous-drone-applications/) ![Advantech Launches ASR-D501 AI Companion Computer for Autonomous Drone Applications](https://i0.wp.com/mmx.prnasia.com/media/MS1998266/20260929040808EDT_image_1.jpg?resize=260%2C140&ssl=1 "Advantech Launches ASR-D501 AI Companion Computer for Autonomous Drone Applications") ## Advantech Launches ASR-D501 AI Companion Computer for Autonomous Drone Applications Compact, power-efficient platform combines edge AI, multi-sensor perception,…